Synonyms: BBI-608 | BBI608
Compound class:
Synthetic organic
Comment: Napabucasin (BBI608) is a small molecule naphthoquinone that blocks cancer stemness properties [3,6], It does this by targeting the signal transducer and activator of transcription 3 (STAT3) pathway [4]. Napabucasin is orally administered, and is bioactivated by the intracellular antioxidant NAD(P)H:quinone oxidoreductase 1 (NQO1), to produce reactive oxygen species (ROS), principally NO. The high level of NO generation causes cell death, and positively correlates with the compound's anti-proliferative activity in cancer cells [1].
COVID-19: Napabucasin has been proposed as a potential repurposing candidate for the treatment of COVID-19, based on a virtual screening analysis of the interaction of existing approved and experimental compounds with the SARS-CoV-2 main protease (Mpro) [2]. Extensive in vitro and in vivo studies would be required to validate napabucasin's antiviral activity. |
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-acetylbenzo[f][1]benzofuran-4,9-dione |
International Nonproprietary Names ![]() |
|
INN number | INN |
9848 | napabucasin |
Synonyms ![]() |
BBI-608 | BBI608 |
Database Links ![]() |
|
BindingDB Ligand | 50366597 |
CAS Registry No. | 83280-65-3 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL64130 |
GtoPdb PubChem SID | 440816727 |
PubChem CID | 10331844 |
Search Google for chemical match using the InChIKey | DPHUWDIXHNQOSY-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | DPHUWDIXHNQOSY |
Search PubMed clinical trials | napabucasin |
Search PubMed titles | napabucasin |
Search PubMed titles/abstracts | napabucasin |
UniChem Compound Search for chemical match using the InChIKey | DPHUWDIXHNQOSY-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | DPHUWDIXHNQOSY-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Napabucasin (links to external site)
Cat. No. HY-13919 |